Sanofi signs latest billion-dollar AI drug discovery deal
November 8, 2022
Join us on November 9 to learn how to successfully innovate and achieve efficiency by upskilling and scaling citizen developers at the Low-Code/No-Code Summit. Register here.
In an era when biopharma research in drug R&D continues to be costly and slow, and artificial intelligence (AI)-based drug discovery platforms are rapidly growing, Paris-based pharmaceutical leader Sanofi announced its…